News & Updates

Between 2013 and 2020, lower extremity amputations (LEA) due to diabetes mellitus (DM) showed a downward trend, according to a recent Singapore study. However, other cardiovascular complications, including peripheral arterial disease (PAD) and ischaemic heart disease (IHD), remain prominent public health concerns.

Among patients with type 2 diabetes (T2D), those who eat two meals per day exhibit higher greater intrapancreatic fat deposition than those who consume three meals per day, a study has found.

First-line treatment with sodium–glucose cotransporter-2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP1) receptor agonists improves outcomes in patients with type 2 diabetes (T2D), but to be cost-effective, the prices of these drugs must drop by at least 70 percent, suggests a study.

Self-management of diabetes through smartphone heath app engagement appears to bring positive changes in disease outcomes such as weight and blood sugar, according to data from the Diabetes Lifestyle Intervention using Technology Empowerment (D’LITE) study.

Mothers who regularly eat ultra-processed foods during the child-rearing period appear to increase the risk of overweight or obesity in their children, irrespective of maternal and offspring lifestyle risk factors, a study has shown.

Using the Steno T1 Risk Engines, the dual SGLT*1 and SGLT2 inhibitor sotagliflozin showed potential in reducing the risk of cardiovascular (CV) and renal disease in adults with type 1 diabetes (T1D).

The use of metformin, fluvoxamine, or ivermectin in an outpatient setting did not appear to prevent progression to severe COVID-19, according to results of the phase III COVID-OUT trial.